TPA 023
CAS: 252977-51-8
Rif. 3D-CKA97751
| 1mg | Prezzo su richiesta | ||
| 5mg | Prezzo su richiesta | ||
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta |
Informazioni sul prodotto
- MK 0777
- 1,2,4-Triazolo[4,3-b]pyridazine, 7-(1,1-dimethylethyl)-6-[(1-ethyl-1H-1,2,4-triazol-5-yl)methoxy]-3-(2-fluorophenyl)-
- 7-(1,1-Dimethylethyl)-6-[(1-ethyl-1H-1,2,4-triazol-5-yl)methoxy]-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine
TPA 023 is a drug that is used in the treatment of anxiety and depression. It has been found to bind with benzodiazepine binding sites, which are receptors that are located on the surface of neurons. These receptors are activated by benzodiazepines, which can cause sedation and relieve anxiety. TPA 023 binds with high affinity to the α1 subunit of GABA-A receptor, which is responsible for mediating neuronal inhibition. TPA 023 has been shown to inhibit the release of epidermal growth factor (EGF) in cultured cells, suggesting that it may be useful in treating skin conditions such as psoriasis. It also inhibits the activity of lorazepam, a nonselective GABA-A receptor agonist.
Proprietà chimiche
Richiesta tecnica su: 3D-CKA97751 TPA 023
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
